nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—attention deficit hyperactivity disorder—Guanfacine—hypertension	0.159	0.697	CpDpCtD
Dextroamphetamine—SLC6A2—hypertension	0.093	0.452	CbGaD
Dextroamphetamine—attention deficit hyperactivity disorder—Clonidine—hypertension	0.0694	0.303	CpDpCtD
Dextroamphetamine—ADRA1A—hypertension	0.0655	0.318	CbGaD
Dextroamphetamine—SLC6A3—hypertension	0.0473	0.23	CbGaD
Dextroamphetamine—SLC18A2—Reserpine—hypertension	0.0355	0.152	CbGbCtD
Dextroamphetamine—Phenacemide—Guanfacine—hypertension	0.0237	0.126	CrCrCtD
Dextroamphetamine—SLC6A2—Guanadrel—hypertension	0.0225	0.0965	CbGbCtD
Dextroamphetamine—Lisdexamfetamine—Labetalol—hypertension	0.0182	0.0972	CrCrCtD
Dextroamphetamine—Aspartame—Quinapril—hypertension	0.0179	0.0952	CrCrCtD
Dextroamphetamine—SLC6A2—Guanethidine—hypertension	0.017	0.0731	CbGbCtD
Dextroamphetamine—Nateglinide—Trandolapril—hypertension	0.0155	0.0825	CrCrCtD
Dextroamphetamine—Nateglinide—Enalapril—hypertension	0.0155	0.0825	CrCrCtD
Dextroamphetamine—Aspartame—Enalapril—hypertension	0.0147	0.0784	CrCrCtD
Dextroamphetamine—Aspartame—Trandolapril—hypertension	0.0147	0.0784	CrCrCtD
Dextroamphetamine—Lisdexamfetamine—Lisinopril—hypertension	0.0136	0.0724	CrCrCtD
Dextroamphetamine—Nateglinide—Lisinopril—hypertension	0.0121	0.0646	CrCrCtD
Dextroamphetamine—Nateglinide—Ramipril—hypertension	0.0117	0.0626	CrCrCtD
Dextroamphetamine—Aspartame—Lisinopril—hypertension	0.0115	0.0613	CrCrCtD
Dextroamphetamine—ADRA1B—Terazosin—hypertension	0.0113	0.0485	CbGbCtD
Dextroamphetamine—Aspartame—Ramipril—hypertension	0.0111	0.0594	CrCrCtD
Dextroamphetamine—ADRA1B—Fenoldopam—hypertension	0.0102	0.0439	CbGbCtD
Dextroamphetamine—ADRA1B—Doxazosin—hypertension	0.00944	0.0405	CbGbCtD
Dextroamphetamine—ADRA1A—Terazosin—hypertension	0.00892	0.0383	CbGbCtD
Dextroamphetamine—ADRA1A—Fenoldopam—hypertension	0.00807	0.0346	CbGbCtD
Dextroamphetamine—ADRA1B—Prazosin—hypertension	0.00775	0.0333	CbGbCtD
Dextroamphetamine—ADRA1A—Doxazosin—hypertension	0.00744	0.0319	CbGbCtD
Dextroamphetamine—Benzphetamine—Bepridil—hypertension	0.00737	0.0393	CrCrCtD
Dextroamphetamine—ADRA1B—Nicardipine—hypertension	0.00669	0.0287	CbGbCtD
Dextroamphetamine—ADRA1B—Carvedilol—hypertension	0.00669	0.0287	CbGbCtD
Dextroamphetamine—ADRA1A—Prazosin—hypertension	0.00611	0.0262	CbGbCtD
Dextroamphetamine—ADRA1B—Clonidine—hypertension	0.00587	0.0252	CbGbCtD
Dextroamphetamine—SLC6A2—Clonidine—hypertension	0.00536	0.023	CbGbCtD
Dextroamphetamine—ADRA1A—Carvedilol—hypertension	0.00528	0.0226	CbGbCtD
Dextroamphetamine—ADRA1A—Nicardipine—hypertension	0.00528	0.0226	CbGbCtD
Dextroamphetamine—ADRA1B—vas deferens—hypertension	0.00497	0.349	CbGeAlD
Dextroamphetamine—ADRA1A—Clonidine—hypertension	0.00463	0.0199	CbGbCtD
Dextroamphetamine—CYP2D6—Labetalol—hypertension	0.00387	0.0166	CbGbCtD
Dextroamphetamine—CYP2D6—Nebivolol—hypertension	0.00387	0.0166	CbGbCtD
Dextroamphetamine—CYP2D6—Acebutolol—hypertension	0.00354	0.0152	CbGbCtD
Dextroamphetamine—CYP2D6—Metoprolol—hypertension	0.00329	0.0141	CbGbCtD
Dextroamphetamine—CYP2D6—Pindolol—hypertension	0.00329	0.0141	CbGbCtD
Dextroamphetamine—CYP2D6—Betaxolol—hypertension	0.00293	0.0126	CbGbCtD
Dextroamphetamine—CYP2D6—Doxazosin—hypertension	0.00258	0.0111	CbGbCtD
Dextroamphetamine—CYP2D6—Diltiazem—hypertension	0.00249	0.0107	CbGbCtD
Dextroamphetamine—CYP2D6—Bepridil—hypertension	0.00222	0.00954	CbGbCtD
Dextroamphetamine—CYP2D6—Irbesartan—hypertension	0.00203	0.00872	CbGbCtD
Dextroamphetamine—CYP2D6—Amlodipine—hypertension	0.00199	0.00856	CbGbCtD
Dextroamphetamine—CYP2D6—Felodipine—hypertension	0.00192	0.00825	CbGbCtD
Dextroamphetamine—CYP2D6—Timolol—hypertension	0.00189	0.00811	CbGbCtD
Dextroamphetamine—CYP2D6—Nifedipine—hypertension	0.00186	0.00798	CbGbCtD
Dextroamphetamine—CYP2D6—Carvedilol—hypertension	0.00183	0.00786	CbGbCtD
Dextroamphetamine—CYP2D6—Nicardipine—hypertension	0.00183	0.00786	CbGbCtD
Dextroamphetamine—SLC6A2—locus ceruleus—hypertension	0.00172	0.121	CbGeAlD
Dextroamphetamine—CYP2D6—Propranolol—hypertension	0.00168	0.00723	CbGbCtD
Dextroamphetamine—CYP2D6—Captopril—hypertension	0.00166	0.00714	CbGbCtD
Dextroamphetamine—CYP2D6—Clonidine—hypertension	0.00161	0.0069	CbGbCtD
Dextroamphetamine—CYP2D6—Atorvastatin—hypertension	0.00143	0.00615	CbGbCtD
Dextroamphetamine—SLC6A2—sympathetic nervous system—hypertension	0.00136	0.0958	CbGeAlD
Dextroamphetamine—CYP2D6—Verapamil—hypertension	0.00116	0.00496	CbGbCtD
Dextroamphetamine—SLC6A2—autonomic nervous system—hypertension	0.000916	0.0644	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—hypertension	0.000538	0.0378	CbGeAlD
Dextroamphetamine—CYP2D6—urine—hypertension	0.000409	0.0287	CbGeAlD
Dextroamphetamine—SLC18A2—brainstem—hypertension	0.000362	0.0255	CbGeAlD
Dextroamphetamine—ADRA1B—kidney—hypertension	0.000292	0.0205	CbGeAlD
Dextroamphetamine—SLC6A3—brainstem—hypertension	0.000274	0.0193	CbGeAlD
Dextroamphetamine—SLC18A2—medulla oblongata—hypertension	0.000253	0.0178	CbGeAlD
Dextroamphetamine—SLC18A2—adrenal gland—hypertension	0.000234	0.0164	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—hypertension	0.000221	0.0155	CbGeAlD
Dextroamphetamine—Bethanidine—KCNJ1—hypertension	0.000217	0.0975	CrCbGaD
Dextroamphetamine—ADRA1A—brainstem—hypertension	0.000206	0.0145	CbGeAlD
Dextroamphetamine—SLC18A2—endocrine gland—hypertension	0.000203	0.0143	CbGeAlD
Dextroamphetamine—SLC6A2—decidua—hypertension	0.000186	0.0131	CbGeAlD
Dextroamphetamine—ADRA1B—central nervous system—hypertension	0.000185	0.013	CbGeAlD
Dextroamphetamine—SLC18A2—central nervous system—hypertension	0.000183	0.0129	CbGeAlD
Dextroamphetamine—ADRA1A—heart—hypertension	0.000178	0.0125	CbGeAlD
Dextroamphetamine—ADRA1A—cardiovascular system—hypertension	0.000168	0.0118	CbGeAlD
Dextroamphetamine—SLC6A2—medulla oblongata—hypertension	0.000154	0.0108	CbGeAlD
Dextroamphetamine—Phenformin—KCNJ8—hypertension	0.000148	0.0668	CrCbGaD
Dextroamphetamine—SLC6A2—adrenal gland—hypertension	0.000143	0.01	CbGeAlD
Dextroamphetamine—SLC6A3—central nervous system—hypertension	0.000138	0.00972	CbGeAlD
Dextroamphetamine—ADRA1A—adrenal gland—hypertension	0.000133	0.00933	CbGeAlD
Dextroamphetamine—SLC6A2—endocrine gland—hypertension	0.000124	0.0087	CbGeAlD
Dextroamphetamine—CYP2D6—brainstem—hypertension	0.000121	0.00851	CbGeAlD
Dextroamphetamine—ADRA1A—endocrine gland—hypertension	0.000115	0.00809	CbGeAlD
Dextroamphetamine—SLC6A2—central nervous system—hypertension	0.000112	0.00784	CbGeAlD
Dextroamphetamine—ADRA1A—central nervous system—hypertension	0.000104	0.00729	CbGeAlD
Dextroamphetamine—Diethylpropion—SLC6A2—hypertension	0.000101	0.0456	CrCbGaD
Dextroamphetamine—CYP2D6—kidney—hypertension	9.67e-05	0.0068	CbGeAlD
Dextroamphetamine—Bethanidine—SLC6A2—hypertension	8.89e-05	0.04	CrCbGaD
Dextroamphetamine—Mephentermine—ADRA1A—hypertension	8.09e-05	0.0364	CrCbGaD
Dextroamphetamine—Lisdexamfetamine—SLC6A2—hypertension	7.67e-05	0.0345	CrCbGaD
Dextroamphetamine—Phenelzine—ABAT—hypertension	7.03e-05	0.0317	CrCbGaD
Dextroamphetamine—Tolazoline—ADRA2B—hypertension	7.01e-05	0.0316	CrCbGaD
Dextroamphetamine—CYP2D6—endocrine gland—hypertension	6.78e-05	0.00476	CbGeAlD
Dextroamphetamine—CYP2D6—central nervous system—hypertension	6.11e-05	0.00429	CbGeAlD
Dextroamphetamine—Ephedrine—SLC6A2—hypertension	6e-05	0.027	CrCbGaD
Dextroamphetamine—Benzyl alcohol—ALDH2—hypertension	5.86e-05	0.0264	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—SLC6A2—hypertension	5.39e-05	0.0242	CrCbGaD
Dextroamphetamine—L-Phenylalanine—TH—hypertension	5.3e-05	0.0239	CrCbGaD
Dextroamphetamine—Diethylpropion—SLC6A3—hypertension	5.15e-05	0.0232	CrCbGaD
Dextroamphetamine—Phentermine—SLC6A2—hypertension	4.8e-05	0.0216	CrCbGaD
Dextroamphetamine—Pseudoephedrine—SLC6A2—hypertension	4.55e-05	0.0205	CrCbGaD
Dextroamphetamine—Tolazoline—ADRA1A—hypertension	4.34e-05	0.0195	CrCbGaD
Dextroamphetamine—Ephedrine—ADRA1A—hypertension	4.23e-05	0.019	CrCbGaD
Dextroamphetamine—Lisdexamfetamine—SLC6A3—hypertension	3.9e-05	0.0176	CrCbGaD
Dextroamphetamine—Methamphetamine—ADRA2B—hypertension	3.89e-05	0.0175	CrCbGaD
Dextroamphetamine—Nateglinide—KCNJ11—hypertension	3.81e-05	0.0172	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRA1A—hypertension	3.79e-05	0.0171	CrCbGaD
Dextroamphetamine—Lacosamide—CA9—hypertension	3.75e-05	0.0169	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A2—hypertension	3.69e-05	0.0166	CrCbGaD
Dextroamphetamine—Methamphetamine—SLC6A2—hypertension	3.42e-05	0.0154	CrCbGaD
Dextroamphetamine—Benzphetamine—SLC6A2—hypertension	3.39e-05	0.0153	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRA1A—hypertension	3.21e-05	0.0144	CrCbGaD
Dextroamphetamine—Tolazoline—ADRA2A—hypertension	3.07e-05	0.0138	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—SLC6A3—hypertension	2.74e-05	0.0123	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRA2A—hypertension	2.69e-05	0.0121	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB1—hypertension	2.68e-05	0.0121	CrCbGaD
Dextroamphetamine—Ephedrine—ADRB2—hypertension	2.52e-05	0.0113	CrCbGaD
Dextroamphetamine—Phentermine—SLC6A3—hypertension	2.44e-05	0.011	CrCbGaD
Dextroamphetamine—Benzphetamine—ADRA1A—hypertension	2.39e-05	0.0108	CrCbGaD
Dextroamphetamine—Pseudoephedrine—SLC6A3—hypertension	2.32e-05	0.0104	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRA2A—hypertension	2.27e-05	0.0102	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB1—hypertension	2.27e-05	0.0102	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—ADRB2—hypertension	2.26e-05	0.0102	CrCbGaD
Dextroamphetamine—Pseudoephedrine—TNF—hypertension	2.15e-05	0.00968	CrCbGaD
Dextroamphetamine—Nateglinide—PPARG—hypertension	2.11e-05	0.0095	CrCbGaD
Dextroamphetamine—Nateglinide—CYP3A5—hypertension	2.1e-05	0.00947	CrCbGaD
Dextroamphetamine—Phenelzine—CYP3A5—hypertension	2.07e-05	0.00933	CrCbGaD
Dextroamphetamine—Pseudoephedrine—ADRB2—hypertension	1.91e-05	0.00858	CrCbGaD
Dextroamphetamine—Amphetamine—SLC6A3—hypertension	1.88e-05	0.00845	CrCbGaD
Dextroamphetamine—Dermatitis—Carvedilol—hypertension	1.88e-05	0.000236	CcSEcCtD
Dextroamphetamine—Anxiety—Timolol—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Angioedema—Lisinopril—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Vomiting—Doxazosin—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Decreased appetite—Losartan—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Irbesartan—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Clonidine—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Body temperature increased—Captopril—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Abdominal pain—Captopril—hypertension	1.87e-05	0.000235	CcSEcCtD
Dextroamphetamine—Headache—Carvedilol—hypertension	1.86e-05	0.000234	CcSEcCtD
Dextroamphetamine—Rash—Doxazosin—hypertension	1.86e-05	0.000233	CcSEcCtD
Dextroamphetamine—Fatigue—Losartan—hypertension	1.85e-05	0.000233	CcSEcCtD
Dextroamphetamine—Dermatitis—Doxazosin—hypertension	1.85e-05	0.000233	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Hydrochlorothiazide—hypertension	1.85e-05	0.000233	CcSEcCtD
Dextroamphetamine—Vomiting—Fosinopril—hypertension	1.85e-05	0.000232	CcSEcCtD
Dextroamphetamine—Nausea—Propranolol—hypertension	1.84e-05	0.000232	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Ramipril—hypertension	1.84e-05	0.000232	CcSEcCtD
Dextroamphetamine—Headache—Doxazosin—hypertension	1.84e-05	0.000232	CcSEcCtD
Dextroamphetamine—Dry mouth—Timolol—hypertension	1.84e-05	0.000231	CcSEcCtD
Dextroamphetamine—Constipation—Losartan—hypertension	1.84e-05	0.000231	CcSEcCtD
Dextroamphetamine—Vomiting—Eplerenone—hypertension	1.84e-05	0.000231	CcSEcCtD
Dextroamphetamine—Rash—Fosinopril—hypertension	1.83e-05	0.00023	CcSEcCtD
Dextroamphetamine—Dermatitis—Fosinopril—hypertension	1.83e-05	0.00023	CcSEcCtD
Dextroamphetamine—Phentermine—SLC6A4—hypertension	1.83e-05	0.00822	CrCbGaD
Dextroamphetamine—Vomiting—Nifedipine—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Furosemide—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Rash—Eplerenone—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Urticaria—Perindopril—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Headache—Fosinopril—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Trandolapril—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Dermatitis—Eplerenone—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Diarrhoea—Valsartan—hypertension	1.82e-05	0.000229	CcSEcCtD
Dextroamphetamine—Asthenia—Clonidine—hypertension	1.82e-05	0.000228	CcSEcCtD
Dextroamphetamine—Vomiting—Verapamil—hypertension	1.82e-05	0.000228	CcSEcCtD
Dextroamphetamine—Urticaria—Irbesartan—hypertension	1.82e-05	0.000228	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Enalapril—hypertension	1.81e-05	0.000228	CcSEcCtD
Dextroamphetamine—Body temperature increased—Perindopril—hypertension	1.81e-05	0.000228	CcSEcCtD
Dextroamphetamine—Abdominal pain—Perindopril—hypertension	1.81e-05	0.000228	CcSEcCtD
Dextroamphetamine—Palpitations—Lisinopril—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Diarrhoea—Olmesartan—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Headache—Eplerenone—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Rash—Nifedipine—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Dermatitis—Nifedipine—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Body temperature increased—Irbesartan—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Abdominal pain—Irbesartan—hypertension	1.81e-05	0.000227	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Timolol—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Rash—Verapamil—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Urticaria—Hydrochlorothiazide—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Tachycardia—Ramipril—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Dermatitis—Verapamil—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Headache—Nifedipine—hypertension	1.8e-05	0.000226	CcSEcCtD
Dextroamphetamine—Abdominal pain—Hydrochlorothiazide—hypertension	1.79e-05	0.000225	CcSEcCtD
Dextroamphetamine—Body temperature increased—Hydrochlorothiazide—hypertension	1.79e-05	0.000225	CcSEcCtD
Dextroamphetamine—Infection—Timolol—hypertension	1.79e-05	0.000225	CcSEcCtD
Dextroamphetamine—Headache—Verapamil—hypertension	1.79e-05	0.000225	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Telmisartan—hypertension	1.79e-05	0.000225	CcSEcCtD
Dextroamphetamine—Nausea—Diltiazem—hypertension	1.79e-05	0.000224	CcSEcCtD
Dextroamphetamine—Nausea—Indapamide—hypertension	1.79e-05	0.000224	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Ramipril—hypertension	1.78e-05	0.000224	CcSEcCtD
Dextroamphetamine—Asthenia—Trandolapril—hypertension	1.77e-05	0.000223	CcSEcCtD
Dextroamphetamine—Urticaria—Furosemide—hypertension	1.77e-05	0.000222	CcSEcCtD
Dextroamphetamine—Nausea—Carvedilol—hypertension	1.77e-05	0.000222	CcSEcCtD
Dextroamphetamine—Asthenia—Enalapril—hypertension	1.77e-05	0.000222	CcSEcCtD
Dextroamphetamine—Body temperature increased—Furosemide—hypertension	1.76e-05	0.000221	CcSEcCtD
Dextroamphetamine—Abdominal pain—Furosemide—hypertension	1.76e-05	0.000221	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Losartan—hypertension	1.76e-05	0.000221	CcSEcCtD
Dextroamphetamine—Dizziness—Valsartan—hypertension	1.76e-05	0.000221	CcSEcCtD
Dextroamphetamine—Anorexia—Ramipril—hypertension	1.76e-05	0.000221	CcSEcCtD
Dextroamphetamine—Urticaria—Betaxolol—hypertension	1.75e-05	0.00022	CcSEcCtD
Dextroamphetamine—Dizziness—Olmesartan—hypertension	1.75e-05	0.00022	CcSEcCtD
Dextroamphetamine—Nausea—Doxazosin—hypertension	1.75e-05	0.00022	CcSEcCtD
Dextroamphetamine—Chest pain—Lisinopril—hypertension	1.75e-05	0.000219	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betaxolol—hypertension	1.74e-05	0.000219	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Timolol—hypertension	1.74e-05	0.000219	CcSEcCtD
Dextroamphetamine—Asthenia—Telmisartan—hypertension	1.74e-05	0.000219	CcSEcCtD
Dextroamphetamine—Methamphetamine—SLC6A3—hypertension	1.74e-05	0.00783	CrCbGaD
Dextroamphetamine—Anxiety—Lisinopril—hypertension	1.74e-05	0.000218	CcSEcCtD
Dextroamphetamine—Diarrhoea—Clonidine—hypertension	1.73e-05	0.000218	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—SLC6A4—hypertension	1.73e-05	0.00779	CrCbGaD
Dextroamphetamine—Nausea—Fosinopril—hypertension	1.73e-05	0.000217	CcSEcCtD
Dextroamphetamine—Benzphetamine—SLC6A3—hypertension	1.73e-05	0.00777	CrCbGaD
Dextroamphetamine—Anorexia—Timolol—hypertension	1.72e-05	0.000216	CcSEcCtD
Dextroamphetamine—Nausea—Eplerenone—hypertension	1.72e-05	0.000216	CcSEcCtD
Dextroamphetamine—Urticaria—Losartan—hypertension	1.71e-05	0.000215	CcSEcCtD
Dextroamphetamine—Dry mouth—Lisinopril—hypertension	1.71e-05	0.000214	CcSEcCtD
Dextroamphetamine—Methamphetamine—ADRA2A—hypertension	1.71e-05	0.00768	CrCbGaD
Dextroamphetamine—Nausea—Nifedipine—hypertension	1.7e-05	0.000214	CcSEcCtD
Dextroamphetamine—Abdominal pain—Losartan—hypertension	1.7e-05	0.000214	CcSEcCtD
Dextroamphetamine—Body temperature increased—Losartan—hypertension	1.7e-05	0.000214	CcSEcCtD
Dextroamphetamine—Nausea—Verapamil—hypertension	1.7e-05	0.000213	CcSEcCtD
Dextroamphetamine—Asthenia—Captopril—hypertension	1.69e-05	0.000213	CcSEcCtD
Dextroamphetamine—Benzphetamine—ADRA2A—hypertension	1.69e-05	0.00761	CrCbGaD
Dextroamphetamine—Diarrhoea—Trandolapril—hypertension	1.69e-05	0.000212	CcSEcCtD
Dextroamphetamine—Vomiting—Valsartan—hypertension	1.69e-05	0.000212	CcSEcCtD
Dextroamphetamine—Diarrhoea—Enalapril—hypertension	1.69e-05	0.000212	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Irbesartan—hypertension	1.68e-05	0.000212	CcSEcCtD
Dextroamphetamine—Vomiting—Olmesartan—hypertension	1.68e-05	0.000211	CcSEcCtD
Dextroamphetamine—Rash—Valsartan—hypertension	1.68e-05	0.000211	CcSEcCtD
Dextroamphetamine—Dizziness—Clonidine—hypertension	1.68e-05	0.000211	CcSEcCtD
Dextroamphetamine—Dermatitis—Valsartan—hypertension	1.68e-05	0.00021	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Lisinopril—hypertension	1.67e-05	0.00021	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Hydrochlorothiazide—hypertension	1.67e-05	0.00021	CcSEcCtD
Dextroamphetamine—Rash—Olmesartan—hypertension	1.67e-05	0.00021	CcSEcCtD
Dextroamphetamine—Insomnia—Ramipril—hypertension	1.67e-05	0.00021	CcSEcCtD
Dextroamphetamine—Dermatitis—Olmesartan—hypertension	1.67e-05	0.000209	CcSEcCtD
Dextroamphetamine—Headache—Valsartan—hypertension	1.67e-05	0.000209	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP1A1—hypertension	1.66e-05	0.00748	CrCbGaD
Dextroamphetamine—Diarrhoea—Telmisartan—hypertension	1.66e-05	0.000209	CcSEcCtD
Dextroamphetamine—Infection—Lisinopril—hypertension	1.66e-05	0.000209	CcSEcCtD
Dextroamphetamine—Headache—Olmesartan—hypertension	1.66e-05	0.000208	CcSEcCtD
Dextroamphetamine—Asthenia—Perindopril—hypertension	1.65e-05	0.000207	CcSEcCtD
Dextroamphetamine—Dyspnoea—Ramipril—hypertension	1.64e-05	0.000207	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Furosemide—hypertension	1.64e-05	0.000206	CcSEcCtD
Dextroamphetamine—Asthenia—Irbesartan—hypertension	1.64e-05	0.000206	CcSEcCtD
Dextroamphetamine—Somnolence—Ramipril—hypertension	1.64e-05	0.000206	CcSEcCtD
Dextroamphetamine—Dizziness—Trandolapril—hypertension	1.64e-05	0.000205	CcSEcCtD
Dextroamphetamine—Tachycardia—Lisinopril—hypertension	1.63e-05	0.000205	CcSEcCtD
Dextroamphetamine—Insomnia—Timolol—hypertension	1.63e-05	0.000205	CcSEcCtD
Dextroamphetamine—Dizziness—Enalapril—hypertension	1.63e-05	0.000205	CcSEcCtD
Dextroamphetamine—Asthenia—Hydrochlorothiazide—hypertension	1.63e-05	0.000204	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Betaxolol—hypertension	1.63e-05	0.000204	CcSEcCtD
Dextroamphetamine—Dyspepsia—Ramipril—hypertension	1.62e-05	0.000204	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Lisinopril—hypertension	1.62e-05	0.000203	CcSEcCtD
Dextroamphetamine—Diarrhoea—Captopril—hypertension	1.62e-05	0.000203	CcSEcCtD
Dextroamphetamine—Vomiting—Clonidine—hypertension	1.61e-05	0.000202	CcSEcCtD
Dextroamphetamine—Dyspnoea—Timolol—hypertension	1.61e-05	0.000202	CcSEcCtD
Dextroamphetamine—Dizziness—Telmisartan—hypertension	1.61e-05	0.000202	CcSEcCtD
Dextroamphetamine—Decreased appetite—Ramipril—hypertension	1.6e-05	0.000201	CcSEcCtD
Dextroamphetamine—Somnolence—Timolol—hypertension	1.6e-05	0.000201	CcSEcCtD
Dextroamphetamine—Asthenia—Furosemide—hypertension	1.6e-05	0.000201	CcSEcCtD
Dextroamphetamine—Rash—Clonidine—hypertension	1.6e-05	0.000201	CcSEcCtD
Dextroamphetamine—Dermatitis—Clonidine—hypertension	1.6e-05	0.000201	CcSEcCtD
Dextroamphetamine—Anorexia—Lisinopril—hypertension	1.59e-05	0.0002	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Ramipril—hypertension	1.59e-05	0.0002	CcSEcCtD
Dextroamphetamine—Fatigue—Ramipril—hypertension	1.59e-05	0.0002	CcSEcCtD
Dextroamphetamine—Headache—Clonidine—hypertension	1.59e-05	0.000199	CcSEcCtD
Dextroamphetamine—Dyspepsia—Timolol—hypertension	1.59e-05	0.000199	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Losartan—hypertension	1.58e-05	0.000199	CcSEcCtD
Dextroamphetamine—Asthenia—Betaxolol—hypertension	1.58e-05	0.000199	CcSEcCtD
Dextroamphetamine—Nausea—Valsartan—hypertension	1.58e-05	0.000198	CcSEcCtD
Dextroamphetamine—Constipation—Ramipril—hypertension	1.58e-05	0.000198	CcSEcCtD
Dextroamphetamine—Nausea—Olmesartan—hypertension	1.57e-05	0.000197	CcSEcCtD
Dextroamphetamine—Vomiting—Trandolapril—hypertension	1.57e-05	0.000197	CcSEcCtD
Dextroamphetamine—Diarrhoea—Perindopril—hypertension	1.57e-05	0.000197	CcSEcCtD
Dextroamphetamine—Decreased appetite—Timolol—hypertension	1.57e-05	0.000197	CcSEcCtD
Dextroamphetamine—Vomiting—Enalapril—hypertension	1.57e-05	0.000197	CcSEcCtD
Dextroamphetamine—Diarrhoea—Irbesartan—hypertension	1.56e-05	0.000196	CcSEcCtD
Dextroamphetamine—Dizziness—Captopril—hypertension	1.56e-05	0.000196	CcSEcCtD
Dextroamphetamine—Nateglinide—PTGS1—hypertension	1.56e-05	0.00702	CrCbGaD
Dextroamphetamine—Rash—Trandolapril—hypertension	1.56e-05	0.000196	CcSEcCtD
Dextroamphetamine—Dermatitis—Trandolapril—hypertension	1.56e-05	0.000196	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Timolol—hypertension	1.56e-05	0.000196	CcSEcCtD
Dextroamphetamine—Fatigue—Timolol—hypertension	1.55e-05	0.000195	CcSEcCtD
Dextroamphetamine—Rash—Enalapril—hypertension	1.55e-05	0.000195	CcSEcCtD
Dextroamphetamine—Dermatitis—Enalapril—hypertension	1.55e-05	0.000195	CcSEcCtD
Dextroamphetamine—Diarrhoea—Hydrochlorothiazide—hypertension	1.55e-05	0.000195	CcSEcCtD
Dextroamphetamine—Headache—Trandolapril—hypertension	1.55e-05	0.000195	CcSEcCtD
Dextroamphetamine—Vomiting—Telmisartan—hypertension	1.54e-05	0.000194	CcSEcCtD
Dextroamphetamine—Asthenia—Losartan—hypertension	1.54e-05	0.000194	CcSEcCtD
Dextroamphetamine—Headache—Enalapril—hypertension	1.54e-05	0.000194	CcSEcCtD
Dextroamphetamine—Rash—Telmisartan—hypertension	1.53e-05	0.000192	CcSEcCtD
Dextroamphetamine—Dermatitis—Telmisartan—hypertension	1.53e-05	0.000192	CcSEcCtD
Dextroamphetamine—Diarrhoea—Furosemide—hypertension	1.53e-05	0.000192	CcSEcCtD
Dextroamphetamine—Headache—Telmisartan—hypertension	1.52e-05	0.000191	CcSEcCtD
Dextroamphetamine—Dizziness—Perindopril—hypertension	1.52e-05	0.00019	CcSEcCtD
Dextroamphetamine—Insomnia—Lisinopril—hypertension	1.51e-05	0.00019	CcSEcCtD
Dextroamphetamine—Dizziness—Irbesartan—hypertension	1.51e-05	0.00019	CcSEcCtD
Dextroamphetamine—Diarrhoea—Betaxolol—hypertension	1.51e-05	0.00019	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Ramipril—hypertension	1.51e-05	0.000189	CcSEcCtD
Dextroamphetamine—Nausea—Clonidine—hypertension	1.51e-05	0.000189	CcSEcCtD
Dextroamphetamine—Vomiting—Captopril—hypertension	1.5e-05	0.000189	CcSEcCtD
Dextroamphetamine—Dizziness—Hydrochlorothiazide—hypertension	1.5e-05	0.000188	CcSEcCtD
Dextroamphetamine—Dyspnoea—Lisinopril—hypertension	1.49e-05	0.000187	CcSEcCtD
Dextroamphetamine—Rash—Captopril—hypertension	1.49e-05	0.000187	CcSEcCtD
Dextroamphetamine—Dermatitis—Captopril—hypertension	1.49e-05	0.000187	CcSEcCtD
Dextroamphetamine—Somnolence—Lisinopril—hypertension	1.49e-05	0.000187	CcSEcCtD
Dextroamphetamine—Headache—Captopril—hypertension	1.48e-05	0.000186	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Timolol—hypertension	1.47e-05	0.000185	CcSEcCtD
Dextroamphetamine—Dizziness—Furosemide—hypertension	1.47e-05	0.000185	CcSEcCtD
Dextroamphetamine—Dyspepsia—Lisinopril—hypertension	1.47e-05	0.000185	CcSEcCtD
Dextroamphetamine—Diarrhoea—Losartan—hypertension	1.47e-05	0.000185	CcSEcCtD
Dextroamphetamine—Nausea—Trandolapril—hypertension	1.47e-05	0.000184	CcSEcCtD
Dextroamphetamine—Urticaria—Ramipril—hypertension	1.47e-05	0.000184	CcSEcCtD
Dextroamphetamine—Nausea—Enalapril—hypertension	1.46e-05	0.000184	CcSEcCtD
Dextroamphetamine—Dizziness—Betaxolol—hypertension	1.46e-05	0.000183	CcSEcCtD
Dextroamphetamine—Vomiting—Perindopril—hypertension	1.46e-05	0.000183	CcSEcCtD
Dextroamphetamine—Abdominal pain—Ramipril—hypertension	1.46e-05	0.000183	CcSEcCtD
Dextroamphetamine—Body temperature increased—Ramipril—hypertension	1.46e-05	0.000183	CcSEcCtD
Dextroamphetamine—Decreased appetite—Lisinopril—hypertension	1.45e-05	0.000183	CcSEcCtD
Dextroamphetamine—Vomiting—Irbesartan—hypertension	1.45e-05	0.000183	CcSEcCtD
Dextroamphetamine—Rash—Perindopril—hypertension	1.45e-05	0.000182	CcSEcCtD
Dextroamphetamine—Dermatitis—Perindopril—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Lisinopril—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Nausea—Telmisartan—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Fatigue—Lisinopril—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Vomiting—Hydrochlorothiazide—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Rash—Irbesartan—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Dermatitis—Irbesartan—hypertension	1.44e-05	0.000181	CcSEcCtD
Dextroamphetamine—Headache—Perindopril—hypertension	1.44e-05	0.00018	CcSEcCtD
Dextroamphetamine—Urticaria—Timolol—hypertension	1.43e-05	0.00018	CcSEcCtD
Dextroamphetamine—Headache—Irbesartan—hypertension	1.43e-05	0.00018	CcSEcCtD
Dextroamphetamine—Constipation—Lisinopril—hypertension	1.43e-05	0.00018	CcSEcCtD
Dextroamphetamine—Rash—Hydrochlorothiazide—hypertension	1.43e-05	0.00018	CcSEcCtD
Dextroamphetamine—Dermatitis—Hydrochlorothiazide—hypertension	1.43e-05	0.000179	CcSEcCtD
Dextroamphetamine—Abdominal pain—Timolol—hypertension	1.43e-05	0.000179	CcSEcCtD
Dextroamphetamine—Body temperature increased—Timolol—hypertension	1.43e-05	0.000179	CcSEcCtD
Dextroamphetamine—Dizziness—Losartan—hypertension	1.42e-05	0.000179	CcSEcCtD
Dextroamphetamine—Headache—Hydrochlorothiazide—hypertension	1.42e-05	0.000178	CcSEcCtD
Dextroamphetamine—Vomiting—Furosemide—hypertension	1.42e-05	0.000178	CcSEcCtD
Dextroamphetamine—Rash—Furosemide—hypertension	1.41e-05	0.000177	CcSEcCtD
Dextroamphetamine—Dermatitis—Furosemide—hypertension	1.4e-05	0.000176	CcSEcCtD
Dextroamphetamine—Amphetamine—SLC6A4—hypertension	1.4e-05	0.00632	CrCbGaD
Dextroamphetamine—Vomiting—Betaxolol—hypertension	1.4e-05	0.000176	CcSEcCtD
Dextroamphetamine—Nausea—Captopril—hypertension	1.4e-05	0.000176	CcSEcCtD
Dextroamphetamine—Headache—Furosemide—hypertension	1.4e-05	0.000175	CcSEcCtD
Dextroamphetamine—Amphetamine—DRD2—hypertension	1.4e-05	0.00629	CrCbGaD
Dextroamphetamine—Rash—Betaxolol—hypertension	1.39e-05	0.000175	CcSEcCtD
Dextroamphetamine—Dermatitis—Betaxolol—hypertension	1.39e-05	0.000175	CcSEcCtD
Dextroamphetamine—Headache—Betaxolol—hypertension	1.38e-05	0.000174	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Lisinopril—hypertension	1.37e-05	0.000172	CcSEcCtD
Dextroamphetamine—Vomiting—Losartan—hypertension	1.37e-05	0.000172	CcSEcCtD
Dextroamphetamine—Nausea—Perindopril—hypertension	1.36e-05	0.000171	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Ramipril—hypertension	1.36e-05	0.000171	CcSEcCtD
Dextroamphetamine—Nausea—Irbesartan—hypertension	1.36e-05	0.000171	CcSEcCtD
Dextroamphetamine—Rash—Losartan—hypertension	1.36e-05	0.00017	CcSEcCtD
Dextroamphetamine—Dermatitis—Losartan—hypertension	1.36e-05	0.00017	CcSEcCtD
Dextroamphetamine—Headache—Losartan—hypertension	1.35e-05	0.000169	CcSEcCtD
Dextroamphetamine—Nausea—Hydrochlorothiazide—hypertension	1.35e-05	0.000169	CcSEcCtD
Dextroamphetamine—Urticaria—Lisinopril—hypertension	1.33e-05	0.000167	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Timolol—hypertension	1.33e-05	0.000167	CcSEcCtD
Dextroamphetamine—Nausea—Furosemide—hypertension	1.32e-05	0.000166	CcSEcCtD
Dextroamphetamine—Asthenia—Ramipril—hypertension	1.32e-05	0.000166	CcSEcCtD
Dextroamphetamine—Body temperature increased—Lisinopril—hypertension	1.32e-05	0.000166	CcSEcCtD
Dextroamphetamine—Abdominal pain—Lisinopril—hypertension	1.32e-05	0.000166	CcSEcCtD
Dextroamphetamine—Nausea—Betaxolol—hypertension	1.31e-05	0.000165	CcSEcCtD
Dextroamphetamine—Methamphetamine—SLC6A4—hypertension	1.3e-05	0.00586	CrCbGaD
Dextroamphetamine—Asthenia—Timolol—hypertension	1.29e-05	0.000162	CcSEcCtD
Dextroamphetamine—Nausea—Losartan—hypertension	1.28e-05	0.00016	CcSEcCtD
Dextroamphetamine—Diarrhoea—Ramipril—hypertension	1.26e-05	0.000159	CcSEcCtD
Dextroamphetamine—Diarrhoea—Timolol—hypertension	1.23e-05	0.000155	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Lisinopril—hypertension	1.23e-05	0.000155	CcSEcCtD
Dextroamphetamine—Dizziness—Ramipril—hypertension	1.22e-05	0.000153	CcSEcCtD
Dextroamphetamine—Asthenia—Lisinopril—hypertension	1.2e-05	0.000151	CcSEcCtD
Dextroamphetamine—Dizziness—Timolol—hypertension	1.19e-05	0.00015	CcSEcCtD
Dextroamphetamine—Vomiting—Ramipril—hypertension	1.17e-05	0.000147	CcSEcCtD
Dextroamphetamine—Rash—Ramipril—hypertension	1.16e-05	0.000146	CcSEcCtD
Dextroamphetamine—Dermatitis—Ramipril—hypertension	1.16e-05	0.000146	CcSEcCtD
Dextroamphetamine—Headache—Ramipril—hypertension	1.16e-05	0.000145	CcSEcCtD
Dextroamphetamine—Vomiting—Timolol—hypertension	1.15e-05	0.000144	CcSEcCtD
Dextroamphetamine—Diarrhoea—Lisinopril—hypertension	1.14e-05	0.000144	CcSEcCtD
Dextroamphetamine—Rash—Timolol—hypertension	1.14e-05	0.000143	CcSEcCtD
Dextroamphetamine—Dermatitis—Timolol—hypertension	1.14e-05	0.000143	CcSEcCtD
Dextroamphetamine—Headache—Timolol—hypertension	1.13e-05	0.000142	CcSEcCtD
Dextroamphetamine—Dizziness—Lisinopril—hypertension	1.11e-05	0.000139	CcSEcCtD
Dextroamphetamine—Nausea—Ramipril—hypertension	1.1e-05	0.000138	CcSEcCtD
Dextroamphetamine—Nausea—Timolol—hypertension	1.07e-05	0.000135	CcSEcCtD
Dextroamphetamine—Vomiting—Lisinopril—hypertension	1.06e-05	0.000134	CcSEcCtD
Dextroamphetamine—Rash—Lisinopril—hypertension	1.05e-05	0.000132	CcSEcCtD
Dextroamphetamine—Dermatitis—Lisinopril—hypertension	1.05e-05	0.000132	CcSEcCtD
Dextroamphetamine—Headache—Lisinopril—hypertension	1.05e-05	0.000132	CcSEcCtD
Dextroamphetamine—Nausea—Lisinopril—hypertension	9.94e-06	0.000125	CcSEcCtD
Dextroamphetamine—Nateglinide—ALB—hypertension	7.94e-06	0.00357	CrCbGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL6—hypertension	1.69e-06	3.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGFR—hypertension	1.67e-06	3.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITGAV—hypertension	1.67e-06	3.44e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HSPG2—hypertension	1.67e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KNG1—hypertension	1.67e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALCA—hypertension	1.67e-06	3.43e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—POMC—hypertension	1.66e-06	3.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRL—hypertension	1.66e-06	3.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGTR1—hypertension	1.66e-06	3.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HDAC1—hypertension	1.63e-06	3.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STK11—hypertension	1.63e-06	3.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BDKRB2—hypertension	1.63e-06	3.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CCL2—hypertension	1.63e-06	3.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—POMC—hypertension	1.62e-06	3.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—F2—hypertension	1.62e-06	3.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PRKCB—hypertension	1.62e-06	3.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL10—hypertension	1.62e-06	3.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PLG—hypertension	1.61e-06	3.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—RHOA—hypertension	1.61e-06	3.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALOX5—hypertension	1.61e-06	3.31e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GLP1R—hypertension	1.61e-06	3.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRBK1—hypertension	1.61e-06	3.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CNR1—hypertension	1.6e-06	3.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—hypertension	1.6e-06	3.28e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3R1—hypertension	1.59e-06	3.28e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALM2—hypertension	1.58e-06	3.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADRB2—hypertension	1.57e-06	3.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—hypertension	1.56e-06	3.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DRD2—hypertension	1.56e-06	3.21e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR7—hypertension	1.56e-06	3.21e-05	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—hypertension	1.55e-06	3.2e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCE—hypertension	1.55e-06	3.19e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTPN1—hypertension	1.54e-06	3.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GCG—hypertension	1.54e-06	3.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VAV3—hypertension	1.53e-06	3.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFA—hypertension	1.53e-06	3.15e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH2—hypertension	1.51e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KL—hypertension	1.51e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFBR2—hypertension	1.51e-06	3.11e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNB3—hypertension	1.5e-06	3.08e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGFR—hypertension	1.48e-06	3.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITGAV—hypertension	1.48e-06	3.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KNG1—hypertension	1.48e-06	3.05e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AVP—hypertension	1.48e-06	3.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—POMC—hypertension	1.48e-06	3.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALDH2—hypertension	1.47e-06	3.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGTR1—hypertension	1.47e-06	3.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRL—hypertension	1.47e-06	3.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RHOA—hypertension	1.46e-06	3.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GNAS—hypertension	1.46e-06	3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HDAC1—hypertension	1.45e-06	2.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STK11—hypertension	1.45e-06	2.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3R1—hypertension	1.45e-06	2.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CCL2—hypertension	1.44e-06	2.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL10—hypertension	1.44e-06	2.96e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HBA1—hypertension	1.44e-06	2.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PLG—hypertension	1.43e-06	2.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—RHOA—hypertension	1.43e-06	2.95e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP11A1—hypertension	1.43e-06	2.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOB—hypertension	1.43e-06	2.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTK2—hypertension	1.42e-06	2.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—hypertension	1.42e-06	2.92e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3R1—hypertension	1.42e-06	2.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—hypertension	1.41e-06	2.91e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EDN1—hypertension	1.4e-06	2.89e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—hypertension	1.4e-06	2.88e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC9A1—hypertension	1.4e-06	2.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADRB2—hypertension	1.4e-06	2.87e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL5—hypertension	1.39e-06	2.87e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CETP—hypertension	1.39e-06	2.85e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCLC—hypertension	1.39e-06	2.85e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCE—hypertension	1.38e-06	2.84e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LPL—hypertension	1.36e-06	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VAV3—hypertension	1.36e-06	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFA—hypertension	1.36e-06	2.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—H2AFX—hypertension	1.35e-06	2.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RPS6KB1—hypertension	1.35e-06	2.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFRB—hypertension	1.35e-06	2.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFBR2—hypertension	1.34e-06	2.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ADCY5—hypertension	1.33e-06	2.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNB3—hypertension	1.33e-06	2.73e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP17A1—hypertension	1.33e-06	2.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCG—hypertension	1.32e-06	2.73e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ITGB3—hypertension	1.32e-06	2.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCA—hypertension	1.32e-06	2.71e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ENO1—hypertension	1.31e-06	2.7e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS1—hypertension	1.31e-06	2.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AVP—hypertension	1.31e-06	2.7e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—YWHAZ—hypertension	1.31e-06	2.69e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RHOA—hypertension	1.3e-06	2.67e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GNAS—hypertension	1.29e-06	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NGF—hypertension	1.29e-06	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPP1—hypertension	1.29e-06	2.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3R1—hypertension	1.29e-06	2.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—hypertension	1.28e-06	2.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOB—hypertension	1.27e-06	2.61e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CTGF—hypertension	1.26e-06	2.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTK2—hypertension	1.26e-06	2.6e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—hypertension	1.26e-06	2.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR5—hypertension	1.26e-06	2.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCD—hypertension	1.26e-06	2.58e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT2—hypertension	1.25e-06	2.58e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMGCR—hypertension	1.25e-06	2.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EDN1—hypertension	1.25e-06	2.57e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL5—hypertension	1.24e-06	2.55e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HTR2A—hypertension	1.23e-06	2.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—C3—hypertension	1.23e-06	2.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADRA2A—hypertension	1.23e-06	2.52e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LPL—hypertension	1.21e-06	2.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—H2AFX—hypertension	1.2e-06	2.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFRB—hypertension	1.2e-06	2.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RPS6KB1—hypertension	1.2e-06	2.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFB—hypertension	1.19e-06	2.46e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGFR1—hypertension	1.19e-06	2.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ADCY5—hypertension	1.18e-06	2.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCG—hypertension	1.18e-06	2.42e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—hypertension	1.17e-06	2.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ITGB3—hypertension	1.17e-06	2.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCA—hypertension	1.17e-06	2.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AGT—hypertension	1.17e-06	2.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—YWHAZ—hypertension	1.16e-06	2.39e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—TH—hypertension	1.15e-06	2.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NGF—hypertension	1.15e-06	2.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPP1—hypertension	1.15e-06	2.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CALM1—hypertension	1.15e-06	2.36e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CALM2—hypertension	1.14e-06	2.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—LEP—hypertension	1.14e-06	2.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOE—hypertension	1.14e-06	2.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—hypertension	1.14e-06	2.35e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CAV1—hypertension	1.13e-06	2.33e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APOA1—hypertension	1.13e-06	2.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—hypertension	1.12e-06	2.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GCG—hypertension	1.12e-06	2.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC2A4—hypertension	1.12e-06	2.3e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCD—hypertension	1.12e-06	2.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR5—hypertension	1.12e-06	2.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HTR2A—hypertension	1.09e-06	2.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—C3—hypertension	1.09e-06	2.24e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GOT1—hypertension	1.08e-06	2.23e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FN1—hypertension	1.08e-06	2.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PRKCB—hypertension	1.08e-06	2.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—F2—hypertension	1.08e-06	2.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFB—hypertension	1.06e-06	2.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGFR1—hypertension	1.06e-06	2.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH1—hypertension	1.05e-06	2.17e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—STK11—hypertension	1.05e-06	2.16e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP19A1—hypertension	1.05e-06	2.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—hypertension	1.04e-06	2.14e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AGT—hypertension	1.04e-06	2.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CALM1—hypertension	1.02e-06	2.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—LEP—hypertension	1.01e-06	2.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOE—hypertension	1.01e-06	2.09e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CAV1—hypertension	1.01e-06	2.07e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APOA1—hypertension	1e-06	2.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—hypertension	9.94e-07	2.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—POMC—hypertension	9.81e-07	2.02e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COMT—hypertension	9.76e-07	2.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—INS—hypertension	9.76e-07	2.01e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARGC1A—hypertension	9.62e-07	1.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNB3—hypertension	9.62e-07	1.98e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCL2—hypertension	9.6e-07	1.98e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—HMOX1—hypertension	9.58e-07	1.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PRKCB—hypertension	9.57e-07	1.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FN1—hypertension	9.57e-07	1.97e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2—hypertension	9.57e-07	1.97e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—hypertension	9.45e-07	1.95e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IGF1—hypertension	9.44e-07	1.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—hypertension	9.43e-07	1.94e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—hypertension	9.39e-07	1.93e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GNAS—hypertension	9.37e-07	1.93e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH1—hypertension	9.36e-07	1.93e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOB—hypertension	9.18e-07	1.89e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SERPINE1—hypertension	8.96e-07	1.84e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTM1—hypertension	8.93e-07	1.84e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—LPL—hypertension	8.76e-07	1.8e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—POMC—hypertension	8.71e-07	1.79e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF2—hypertension	8.68e-07	1.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—INS—hypertension	8.67e-07	1.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RHOA—hypertension	8.65e-07	1.78e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ADCY5—hypertension	8.58e-07	1.77e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3R1—hypertension	8.56e-07	1.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOS3—hypertension	8.56e-07	1.76e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GPX1—hypertension	8.55e-07	1.76e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCL2—hypertension	8.53e-07	1.75e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP1A1—hypertension	8.46e-07	1.74e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PRKCA—hypertension	8.46e-07	1.74e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IGF1—hypertension	8.38e-07	1.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—hypertension	8.38e-07	1.72e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—hypertension	8.34e-07	1.72e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CD36—hypertension	8.33e-07	1.71e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RELA—hypertension	8.05e-07	1.66e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SERPINE1—hypertension	7.96e-07	1.64e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MTOR—hypertension	7.9e-07	1.62e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—MTHFR—hypertension	7.89e-07	1.62e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARA—hypertension	7.74e-07	1.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF2—hypertension	7.71e-07	1.59e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RHOA—hypertension	7.68e-07	1.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3R1—hypertension	7.6e-07	1.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOS3—hypertension	7.6e-07	1.56e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—hypertension	7.59e-07	1.56e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AGT—hypertension	7.5e-07	1.54e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CALM1—hypertension	7.37e-07	1.52e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOE—hypertension	7.35e-07	1.51e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—hypertension	7.33e-07	1.51e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAV1—hypertension	7.28e-07	1.5e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—APOA1—hypertension	7.26e-07	1.49e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL6—hypertension	7.22e-07	1.48e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RELA—hypertension	7.15e-07	1.47e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MTOR—hypertension	7.02e-07	1.44e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—hypertension	6.86e-07	1.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN1A—hypertension	6.84e-07	1.41e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—hypertension	6.82e-07	1.4e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—hypertension	6.74e-07	1.39e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MAPK8—hypertension	6.68e-07	1.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—hypertension	6.66e-07	1.37e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—hypertension	6.51e-07	1.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EP300—hypertension	6.51e-07	1.34e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL6—hypertension	6.41e-07	1.32e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—hypertension	6.4e-07	1.32e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SRC—hypertension	6.33e-07	1.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—POMC—hypertension	6.31e-07	1.3e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—INS—hypertension	6.27e-07	1.29e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—hypertension	6.16e-07	1.27e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—hypertension	6.1e-07	1.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN1A—hypertension	6.08e-07	1.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—hypertension	6.06e-07	1.25e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MAPK8—hypertension	5.93e-07	1.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—hypertension	5.91e-07	1.22e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EP300—hypertension	5.78e-07	1.19e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ALB—hypertension	5.75e-07	1.18e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—hypertension	5.67e-07	1.17e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TGFB1—hypertension	5.66e-07	1.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SRC—hypertension	5.62e-07	1.16e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—hypertension	5.55e-07	1.14e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NOS3—hypertension	5.5e-07	1.13e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3R1—hypertension	5.5e-07	1.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—hypertension	5.48e-07	1.13e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—hypertension	5.04e-07	1.04e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—hypertension	5.03e-07	1.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TGFB1—hypertension	5.03e-07	1.03e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—hypertension	4.93e-07	1.01e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—hypertension	4.66e-07	9.58e-06	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—hypertension	4.39e-07	9.03e-06	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL6—hypertension	4.26e-07	8.77e-06	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—EP300—hypertension	4.19e-07	8.61e-06	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—hypertension	4.14e-07	8.51e-06	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—hypertension	3.93e-07	8.09e-06	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL6—hypertension	3.79e-07	7.79e-06	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—hypertension	3.49e-07	7.19e-06	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—hypertension	2.53e-07	5.2e-06	CbGpPWpGaD
